Meyer Timothy W, Walther Jason L, Pagtalunan Maria Enrica, Martinez Andres W, Torkamani Ali, Fong Patrick D, Recht Natalie S, Robertson Channing R, Hostetter Thomas H
Department of Medicine, VA Palo Alto Health Care Science, Palo Alto, California 94303, USA.
Kidney Int. 2005 Aug;68(2):867-77. doi: 10.1111/j.1523-1755.2005.00469.x.
Hemofiltration in the form of continuous venovenous hemofiltration (CVVH) is increasingly used to treat acute renal failure. Compared to hemodialysis, hemofiltration provides high clearances for large solutes but its effect on protein-bound solutes has been largely ignored.
Standard clinical systems were used to remove test solutes from a reservoir containing artificial plasma. Clearances of the protein-bound solutes phenol red (C(PR)) and indican (C(IN)) were compared to clearances of urea (C(UREA)) during hemofiltration and hemodiafiltration. A mathematical model was developed to predict clearances from values for plasma flow Q(p), dialysate flow Q(d), ultrafiltration rate Q(f), filter size and the extent of solute binding to albumin.
When hemofiltration was performed with Q(p) 150 mL/min and Q(f) 17 mL/min, clearance values were C(PR) 1.0 +/- 0.1 mL/min; C(IN) 3.7 +/- 0.5 mL/min; and C(UREA) 14 +/- 1 mL/min. The clearance of the protein-bound solutes was approximately equal to the solute-free fraction multiplied by the ultrafiltration rate corrected for the effect of predilution. Addition of Q(d) 42 mL/min to provide HDF while Q(p) remained 150 mL/min resulted in proportional increases in the clearance of protein-bound solutes and urea. In contrast, the clearance of protein-bound solutes relative to urea increased when hemodiafiltration was performed using a larger filter and increasing Q(d) to 300 mL/min while Q(p) was lowered to 50 mL/min. The pattern of observed results was accurately predicted by mathematical modeling.
In vitro measurements and mathematical modeling indicate that CVVH provides very limited clearance of protein-bound solutes. Continuous venous hemodiafiltration (CVVHDF) increases the clearance of protein-bound solutes relative to urea only when dialysate flow rate and filter size are increased above values now commonly employed.
连续性静脉-静脉血液滤过(CVVH)形式的血液滤过越来越多地用于治疗急性肾衰竭。与血液透析相比,血液滤过对大分子溶质具有较高的清除率,但其对蛋白结合溶质的影响在很大程度上被忽视了。
使用标准临床系统从含有人工血浆的储液器中清除测试溶质。在血液滤过和血液透析滤过期间,比较蛋白结合溶质酚红(C(PR))和吲哚苷(C(IN))的清除率与尿素(C(UREA))的清除率。建立了一个数学模型,以根据血浆流量Q(p)、透析液流量Q(d)、超滤率Q(f)、滤器尺寸以及溶质与白蛋白结合程度的值来预测清除率。
当以Q(p) 150 mL/分钟和Q(f) 17 mL/分钟进行血液滤过时,清除率值分别为:C(PR) 1.0±0.1 mL/分钟;C(IN) 3.7±0.5 mL/分钟;C(UREA) 14±1 mL/分钟。蛋白结合溶质的清除率大约等于无溶质分数乘以经预稀释影响校正后的超滤率。在Q(p)保持为150 mL/分钟的情况下,添加Q(d) 42 mL/分钟以进行血液透析滤过,导致蛋白结合溶质和尿素的清除率成比例增加。相比之下,当使用更大的滤器并将Q(d)增加到300 mL/分钟同时将Q(p)降低到50 mL/分钟进行血液透析滤过时,蛋白结合溶质相对于尿素的清除率增加。通过数学建模准确预测了观察到的结果模式。
体外测量和数学建模表明,CVVH对蛋白结合溶质的清除非常有限。仅当透析液流速和滤器尺寸增加到高于目前常用的值时,连续性静脉血液透析滤过(CVVHDF)相对于尿素才会增加蛋白结合溶质的清除率。